Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CARFILZOMIB for Osteosarcoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where CARFILZOMIB was used for Osteosarcoma.

Most Reported Side Effects for CARFILZOMIB

Side Effect Reports % Deaths Hosp.
Plasma cell myeloma 2,238 10.3% 748 426
Off label use 2,120 9.7% 361 393
Death 1,442 6.6% 1,441 249
Thrombocytopenia 1,265 5.8% 284 385
Fatigue 1,048 4.8% 131 205
Pneumonia 1,016 4.7% 334 634
Pyrexia 969 4.4% 170 590
Anaemia 910 4.2% 212 373
Dyspnoea 881 4.0% 141 338
Neutropenia 874 4.0% 190 213
Diarrhoea 764 3.5% 157 285
Acute kidney injury 746 3.4% 201 493
Nausea 707 3.2% 113 194
Disease progression 622 2.9% 166 144
Hypertension 609 2.8% 127 228

Other Indications for CARFILZOMIB

Plasma cell myeloma (15,333) Product used for unknown indication (4,210) Plasma cell myeloma refractory (1,208) Plasma cell leukaemia (186) Off label use (143) Acute lymphocytic leukaemia (86) Plasma cell myeloma recurrent (66) Plasmacytoma (66) Chemotherapy (51) Amyloidosis (44)

Other Drugs Used for Osteosarcoma

METHOTREXATE (1,267) DOXORUBICIN (1,135) CISPLATIN (975) IFOSFAMIDE (845) ETOPOSIDE (531) CARBOPLATIN (169) CABOZANTINIB S-MALATE (116) DOCETAXEL (99) CYCLOPHOSPHAMIDE (92) LENVATINIB (91)

Related Pages

CARFILZOMIB Full Profile All Osteosarcoma Drugs CARFILZOMIB Demographics CARFILZOMIB Timeline